Biologics Outsourcing Market: Driving Growth in Biopharmaceuticals through Contract Development and
The Biologics Outsourcing market involves the delegation of various stages of biologic drug development, manufacturing, and testing processes to contract research organizations (CROs) and contract manufacturing organizations (CMOs). Biologics are complex, large-molecule drugs derived from living organisms and are used to treat a variety of chronic and life-threatening diseases, including cancer, autoimmune disorders, and genetic conditions. Outsourcing in this market allows pharmaceutical companies to access specialized expertise, reduce costs, and accelerate time-to-market for biologic products.